Skip to main content
Top
Published in: Infection 6/2017

01-12-2017 | Original Paper

Clinical characteristics and outcomes of septic bursitis

Authors: Sarah B. Lieber, Mary Louise Fowler, Clara Zhu, Andrew Moore, Robert H. Shmerling, Ziv Paz

Published in: Infection | Issue 6/2017

Login to get access

Abstract

Purpose

Limited data guide practice in evaluation and treatment of septic bursitis. We aimed to characterize clinical characteristics, microbiology, and outcomes of patients with septic bursitis stratified by bursal involvement, presence of trauma, and management type.

Methods

We conducted a retrospective cohort study of adult patients admitted to a single center from 1998 to 2015 with culture-proven olecranon and patellar septic bursitis. Baseline characteristics, clinical features, microbial profiles, operative interventions, hospitalization lengths, and 60-day readmission rates were determined. Patients were stratified by bursitis site, presence or absence of trauma, and operative or non-operative management.

Results

Of 44 cases of septic bursitis, patients with olecranon and patellar bursitis were similar with respect to age, male predominance, and frequency of bursal trauma; patients managed operatively were younger (p = 0.05). Clinical features at presentation and comorbidities were similar despite bursitis site, history of trauma, or management. The most common organism isolated from bursal fluid was Staphylococcus aureus. Patients managed operatively were discharged to rehabilitation less frequently (p = 0.04).

Conclusions

This study of septic bursitis is among the largest reported. We were unable to identify presenting clinical features that differentiated patients treated surgically from those treated conservatively. There was no clear relationship between preceding trauma or bursitis site and clinical course, management, or outcomes. Patients with bursitis treated surgically were younger. Additional study is needed to identify patients who would benefit from early surgical intervention for septic bursitis.
Literature
1.
go back to reference Laupland KB, Davis HD. Olecranon septic bursitis managed in an ambulatory setting. The Calgary Home Parenteral Therapy Program Study Group. Clin Invest Med. 2001;24:171–8.PubMed Laupland KB, Davis HD. Olecranon septic bursitis managed in an ambulatory setting. The Calgary Home Parenteral Therapy Program Study Group. Clin Invest Med. 2001;24:171–8.PubMed
2.
go back to reference Martinez-Taboada VM, et al. Cloxacillin-based therapy in severe septic bursitis: retrospective study of 82 cases. Joint Bone Spine. 2009;76:665–9.CrossRefPubMed Martinez-Taboada VM, et al. Cloxacillin-based therapy in severe septic bursitis: retrospective study of 82 cases. Joint Bone Spine. 2009;76:665–9.CrossRefPubMed
3.
go back to reference Perez C, et al. Infectious olecranon and patellar bursitis: short-course adjuvant antibiotic therapy is not a risk factor for recurrence in adult hospitalized patients. J Antimicrob Chemother. 2010;65:1008–14.CrossRefPubMed Perez C, et al. Infectious olecranon and patellar bursitis: short-course adjuvant antibiotic therapy is not a risk factor for recurrence in adult hospitalized patients. J Antimicrob Chemother. 2010;65:1008–14.CrossRefPubMed
4.
5.
go back to reference Garcia-Porrua C, et al. The clinical spectrum of severe septic bursitis in Northwestern Spain: a 10 year study. J Rheumatol. 1999;26:663–7.PubMed Garcia-Porrua C, et al. The clinical spectrum of severe septic bursitis in Northwestern Spain: a 10 year study. J Rheumatol. 1999;26:663–7.PubMed
6.
go back to reference Ho G, et al. Septic bursitis in the prepatellar and olecranon bursae. An analysis of 25 cases. Ann Intern Med. 1978;89:21–7.CrossRefPubMed Ho G, et al. Septic bursitis in the prepatellar and olecranon bursae. An analysis of 25 cases. Ann Intern Med. 1978;89:21–7.CrossRefPubMed
7.
go back to reference Sayegh ET, Strauch RJ. Treatment of olecranon bursitis: a systematic review. Arch Orthop Trauma Surg. 2014;134:1517–36.CrossRefPubMed Sayegh ET, Strauch RJ. Treatment of olecranon bursitis: a systematic review. Arch Orthop Trauma Surg. 2014;134:1517–36.CrossRefPubMed
8.
go back to reference Cea-Pereiro JC, et al. A comparison between septic bursitis caused by S. aureus and those caused by other organisms. Clin Rheumatol. 2001;20:10–4.CrossRefPubMed Cea-Pereiro JC, et al. A comparison between septic bursitis caused by S. aureus and those caused by other organisms. Clin Rheumatol. 2001;20:10–4.CrossRefPubMed
10.
go back to reference Canoso JJ, Sheckman PR. Septic subcutaneous bursitis. Report of sixteen cases. J Rheumatol. 1979;6:96–102.PubMed Canoso JJ, Sheckman PR. Septic subcutaneous bursitis. Report of sixteen cases. J Rheumatol. 1979;6:96–102.PubMed
11.
go back to reference Soderquist B, Hedstrom SA. Predisposing factors, bacteriology and antibiotic therapy in 35 cases of septic bursitis. Scand J Infect Dis. 1986;18:305–11.CrossRefPubMed Soderquist B, Hedstrom SA. Predisposing factors, bacteriology and antibiotic therapy in 35 cases of septic bursitis. Scand J Infect Dis. 1986;18:305–11.CrossRefPubMed
12.
go back to reference Pien FD, et al. Septic bursitis: experience in a community practice. Orthopedics. 1991;14:981–4.PubMed Pien FD, et al. Septic bursitis: experience in a community practice. Orthopedics. 1991;14:981–4.PubMed
13.
go back to reference Gomez-Rodriguez N, et al. Infectious bursitis: study of 40 cases in the prepatellar and olecranon regions. Enferm Infecc Microbiol Clin. 1997;15:237–42.PubMed Gomez-Rodriguez N, et al. Infectious bursitis: study of 40 cases in the prepatellar and olecranon regions. Enferm Infecc Microbiol Clin. 1997;15:237–42.PubMed
14.
go back to reference Raddatz DA, et al. Septic bursitis: presentation, treatment, and prognosis. J Rheumatol. 1987;14:1160–3.PubMed Raddatz DA, et al. Septic bursitis: presentation, treatment, and prognosis. J Rheumatol. 1987;14:1160–3.PubMed
16.
17.
go back to reference Osmon DR, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56:e1–25.CrossRefPubMed Osmon DR, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56:e1–25.CrossRefPubMed
18.
Metadata
Title
Clinical characteristics and outcomes of septic bursitis
Authors
Sarah B. Lieber
Mary Louise Fowler
Clara Zhu
Andrew Moore
Robert H. Shmerling
Ziv Paz
Publication date
01-12-2017
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 6/2017
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-017-1030-3

Other articles of this Issue 6/2017

Infection 6/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine